Shire, Takeda reach breakthrough in $64 billion deal talks

LONDON/NEW YORK (Reuters) - London-listed drugmaker Shire Plc said on Tuesday it was willing to recommend to its shareholders a deal with Takeda Pharmaceutical Co, after the Japanese company sweetened its acquisition offer to 46 billion pounds ($64 billion).